目的:探讨超声检查在腹部闭合性损伤内脏破裂出血的应用价值。方法:对92例腹部闭合性损伤内脏破裂出血患者进行全面、细致的超声检查,并收集其手术、病理结果。结果:本组病例超声与手术结果完全相符者83例(占90.2%),基本相符者6例(占6.5%),漏诊3例(占3.3%)。其中脾破裂49例,肝破裂16例,肾破裂14例,胰腺损伤1例,肠破裂6例,复合性内脏破裂6例。92例患者均伴有腹腔积液,超声检出率100％(92／92)。结论:超声能迅速、较准确地对腹部闭合性损伤内脏破裂出血作出诊断,尤其诊断实质性脏器破裂比空腔脏器破裂更有特异性,具有重要的临床价值。
ObjectiveTo summarize the current comparison of the efficacy of different treatments for recurrent hepatocellular carcinoma.MethodTo search the literatures about the comparative studies on the efficacy of different treatments for recurrent hepatocellular carcinoma in recent years and analyze them.ResultsIn the treatment of recurrent hepatocellular carcinoma, percutaneous arterial chemoembolization combined with radiofrequency ablation could improve the survival rate and tumor-free survival rate to some extent, compared with the single use of percutaneous arterial chemoembolization. In the short term, there was no difference in efficacy between radiofrequency ablation and surgical resection, but the local recurrence rate of radiofrequency ablation was higher than that of surgical resection group. Salvage liver transplantation offered potential opportunity to reduce the risk of recurrence and tended to improve long-term survival outcomes, but liver sources were scarce and costly. ConclusionsAt present, there is no systematic staging scheme and treatment system for recurrent hepatocellular carcinoma. At the same time, most studies are retrospective, and more prospective studies are needed to further explore the treatment of recurrent hepatocellular carcinoma.
【Abstract】Objective To review the recent advances in the use of marginal liver in liver transplantation. Methods The literatures of recent years on the use of marginal liver for liver transplantation were reviewed and summarized.Results The donors with older age, hemodynamic instability, long stay in the intensive care unit and fatty liver are significantly clinical marginal liver donors.Conclusion Though the use of marginal liver donors negatively influences the results of liver transplantation, marginal liver expands the liver source for liver transplantation with a good result.
【Abstract】ObjectiveTo report the diagnosis and treatment of hilar cholangiocarcinoma.MethodsThe relevant information about the hispathological feature, transfer ways, clinical manifestation, laboratory examination, imaging feature, immunohistochemical examination and treatment ways were gathered from previous original articles, and checking the latest issues of appropriate journals.ResultsThe clinical manifestation, laboratory examination, and imaging feature of hilar cholangiocarcinoma were due to the neoplasm obstructing bile duct and sequent infection of bile duct. The diagnosis was depanded on the combining clinical manifestation, laboratory examination and imaging feature. The value of immunohistochemical examination was not clear. Radical surgery was the best treatment of unique curing the neoplasm. By-pass surgery was used in the late phase patients to solve the obstruction of bile and digest duct. The effect of unique chemical treatment was not perfect. It did’t generally propose the treatment of orthotopic liver transplantation.ConclusionThe perfect prognosis of hilar cholangiocarcinoma is depended on early diagnosis and redical surgery.
【摘要】目的探讨慢性胰腺炎的诊治方法。方法对1997年5月至2002年11月期间所收治并经临床或病理证实的114例慢性胰腺炎患者的资料进行回顾性分析。结果主要临床表现为腹痛、体重下降、腹胀和消化不良。影像学特征为胰腺肿块、假性囊肿、胰管扩张和胰管结石。本组中有60例行外科手术治疗，术后发生并发症4例，死亡1例，其余54例经保守治疗症状缓解。结论慢性胰腺炎临床表现和影像学表现变化多样，应根据病变特点选择手术方式。
Objective To review the development of the liver stem cell transplant for the liver regenerative treatment. Methods The transplantationrelated articles about the stem cell classification, repairing mechanisms, administration routes, and existing problems in the liver regenerative therapies reported in the latest literature were extensively reviewed. Results The related liverrepairing stem cells were found to be inside and outside the liver, i.e., the hepatic stem cells and the nonhepatic stem cells. They could repair the liver by the mechanism of the cell fusion or the celltransdifferentiation. The stem cells could be administrated via the portal vein. However, the application of the liver stem cell transplant was restricted by many related clinical problems. Conclusion Further studies are still needed for an improvement of the clinical feasibility for the stem cell transplantation, especially for the liver stem cell transplantation.